Back to the main directory
EarningsReview / Equity
- Reassuring update by BNP Paribas Exane
- China Merchants Bank (3968 HK/600036 CH) by HSBC
- Tele2 - Welcome predictability by Danske Bank Equity Research
- Momentum Group - Roll-up story in a market with Momentum by Danske Bank Equity Research
- Arjo - Q2 will most likely not be the trigger we are waiting for by Danske Bank Equity Research
- Basware - Hold: Focus on takeover progress by Nordea
- Graenges - Buy/SEK 128 (124): Strong execution offsetting cost inflation by Nordea
- Investor - Hold: Q1 delivery in line with expectations by Nordea
- Metso Outotec - Buy/EUR 9.60 (9.30): Strong performance in Q1 increases confidence by Nordea
- Tele2 - Hold: Healthy performance, reflected in the price by Nordea
- Sandvik (Buy, TP: SEK265.00) - Lowered risk for 2022e by DnB Markets
- Ossur (Buy, TP: DKK48.00) - Q1e: focus on supply chain and costs by DnB Markets
- Lerøy Seafood (Buy, TP: NOK100.00) - Minor model update by DnB Markets
- B2Holding (Buy, TP: NOK13.50) - Investments set to rise in 2022 by DnB Markets
- Vimian (Buy, TP: SEK110.00) - 2022 likely off to a good start by DnB Markets
- Elkem (Buy, TP: NOK50.00) - Harvesting the power arbitrage by DnB Markets
- Tele2 (Hold, TP: SEK150.00) - Fairly valued by DnB Markets
- Rate hikes enticing by DnB Markets
- Diurnal Group - FY21 results reflect puts and takes by Edison Investment Research
- Mirriad Advertising - Targeting the US big guns by Edison Investment Research
- Solid State - Strong finish to FY22 to deliver record profit by Edison Investment Research
- Kinnevik (Hold, TP: SEK210.00) - Fear of more markdowns to come by DnB Markets
- ABB (Hold, TP: SEK345.00) - Raising the bar for 2022e by DnB Markets
- Coloplast (Hold, TP: DKK1000.00) - Covid-19 recovery continues by DnB Markets
- Royal Unibrew (Buy, TP: DKK860.00) - Q1 profit growth looks challenging by DnB Markets
- Q1''22: Inflation hits by BNP Paribas Exane
- ABB - Order bonanza by Danske Bank Equity Research
- Investor - Margin recovery continues by Danske Bank Equity Research
- Hansa Biopharma - Q1 report solid – but journey just beginning by Danske Bank Equity Research
- Axfood - Buy/SEK 325 (320): Solid Q1 numbers and we expect more ahead by Nordea
- Beijer Ref - Buy/SEK 196 (190): Indisputably strong Q1 by Nordea
- Husqvarna - Hold: Better than our lowered expectations by Nordea
- Kinnevik - Hold: Private market valuations reconciling by Nordea
- Sandvik - Resuming coverage at Hold: On the sidelines for now by Nordea
- SpareBank 1 Sørøst-Norge - Initiation of coverage - The consolidation challenger by DnB Markets
- Mowi (Hold, TP: NOK255.00) - Strong outlook already priced in by DnB Markets
- 2020 Bulkers (Buy, TP: NOK159.00) - Still positive on H2e by DnB Markets
- Beijer Ref (Buy, TP: SEK205.00) - Stricter F-gas regulations to come by DnB Markets
- Husqvarna (Hold, TP: SEK100.00) - Two decisive factors in 2022 by DnB Markets
- Yara (Buy, TP: NOK600.00) - by DnB Markets
- Tomra (Sell, TP: NOK320.00) - Slow Q1e before gearing up by DnB Markets
- April web-activity insights by DnB Markets
- Context Therapeutics - R&D webinar highlights pipeline potential by Edison Investment Research
- Lloyd Fonds - Termination of coverage by Edison Investment Research
- Osirium Technologies - Accelerating bookings by Edison Investment Research
- VinaCapital Vietnam Opportunity Fund - Vietnam carves its own post-COVID niche by Edison Investment Research
- Investor (Buy, TP: SEK230.00) - In good shape by DnB Markets
- Metso Outotec (Buy, TP: EUR11.00) - Order and earnings strength by DnB Markets
- Dometic (Buy, TP: SEK144.00) - Significant upside potential by DnB Markets
- Carlsberg (Buy, TP: DKK1000.00) - Focus on underlying ex Russia by DnB Markets